Approval · Notice of Compliance 14546 · 2013
ERIVEDGE: Notice of Compliance 14546
Issued July 12, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14546
- Date
- July 12, 2013
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERIVEDGE | 02409267 | Marketed |
Medicinal ingredients
- VISMODEGIB 150 MG per CAP